Genetic Risk Factors in Retinoblastoma: What Parents Should Know

Retinoblastoma is a rare but potentially life-threatening eye cancer that primarily affects children under the age of five. As the most common form of malignant eye tumour in young children, retinoblastoma eye cancer requires early recognition and timely medical attention. Understanding its genetic risk factors, hereditary patterns, and related gene mutations can help families identify potential risks and take appropriate steps to protect their child’s vision and overall health.

What Is Retinoblastoma?

To understand what is retinoblastoma, it is a malignant tumour that develops in the retina, the thin layer of tissue at the back of the eye responsible for sensing light and transmitting visual signals to the brain. Key facts include:

Key Insights

• Prevalence: About 1 in 15,000 to 20,000 live births globally.
• Age: Most diagnoses occur before the age of five.
• Laterality: Can affect one eye (unilateral) or both eyes (bilateral). Bilateral cases are more likely due to genetic mutations.

Symptoms

• Leukocoria (white reflection in the pupil)
• Strabismus (crossed eyes)
• Poor vision or eye redness/swelling

Comparison of Unilateral vs. Bilateral Retinoblastoma

Early detection and prompt treatment of retinoblastoma are critical for saving vision, the eye, and preventing metastasis (spread to other parts of the body such as the brain or bones).

The Genetics Behind Retinoblastoma

Genetics play a pivotal role in retinoblastoma. The disease most often results from mutations in the RB1 gene, a tumor suppressor gene located on chromosome 13. Its main function is to regulate the cell cycle and prevent cells from growing uncontrollably.

RB1 Gene Mutation:

• Both copies of the RB1 gene must be altered for a cell to become cancerous.
• Germline (inherited) mutations mean one defective copy is present in all cells at birth, increasing risk.
• Somatic (acquired) mutations occur only in retinal cells and are not inherited.

Mutation Facts:

• Retinoblastoma in children with a germline mutation in the RB1 gene has an approximately 40% penetrance rate, meaning about 40% of children carrying the mutation may develop the condition.
• About 10‒20% of children with retinoblastoma have no family history — these are de novo mutations.
• Germline mutations increase the risk of other cancers later in life (e.g., osteosarcoma).

Did you know?

The discovery of RB1 was pivotal in cancer genetics, marking the first identification of a tumor suppressor gene.

Understanding Genetic Risk Factors

The risk of retinoblastoma is strongly influenced by genetic inheritance:

• If a parent carries an RB1 mutation, each child has a 50% chance of inheriting it.
• Not all children who inherit the mutation develop cancer, but their risk is significantly elevated.
• Families with a history of retinoblastoma benefit greatly from genetic counseling and regular screening.

Key genetic risk factors:

Inherited (Germline) Mutation:

• Found in every cell of the body, including reproductive cells.
• Can be passed to future generations.
• Responsible for nearly all bilateral cases.

Sporadic (Somatic) Mutations:

• Occur only in retinal cells.
• Not inherited or passed on to children.
• Most unilateral cases fall into this category.

Fact Box

• Approximately 60% of retinoblastoma cases are non-hereditary (somatic) and confined to one eye.
• About 40% are hereditary (germline), with a higher likelihood of affecting both eyes and being present at a younger age.

Hereditary vs Non-Hereditary Retinoblastoma

A clear understanding of the distinction between hereditary and non-hereditary retinoblastoma shapes both screening and management approaches.

How Genetic Testing Can Help

Genetic testing utilizes advanced techniques to detect RB1 gene mutations. It enables:

• Identification of at-risk family members before symptoms appear
• Precision diagnosis, guiding treatment decisions
• Reduced need for invasive eye exams under anesthesia in unaffected siblings

Benefits of Genetic Testing:

• Allows early screening and surveillance for those who test positive
• Guides reproductive decisions for parents/families
• Reassurance for those who do not carry the mutation

Testing Process:

• Collection of blood or saliva samples
• DNA analysis to identify RB1 gene mutations
• Results counseling to discuss findings and next steps

Limitations to Keep in Mind:

• Not all mutations are detectable with current technology
• Results may impact family dynamics and psychological well-being—support is vital

Preventive Measures and Early Detection

Early detection significantly improves outcomes and can even save lives. Key preventive and surveillance strategies include:

Routine Eye Examinations:

• Frequent, thorough eye exams for children at risk (including those with a family history)
• Use of tools such as fundus photography, ultrasound, and MRI

Monitoring for Warning Signs:

• Leukocoria (white reflection in the pupil—often the first sign noticed in photographs)
• Strabismus or misaligned eyes
• Poor vision or unexplained changes in a child’s eye appearance

Parent Action Checklist:

• Be vigilant for changes in your child’s eye or vision
• Attend all scheduled pediatric eye appointments
• Inform your child’s doctor about any family history of retinoblastoma or eye cancer

Fact: Early diagnosis improves the survival rate of retinoblastoma above 95% in developed countries.

Surveillance for High-Risk Children

Close, lifelong monitoring is essential for children with hereditary risk. Best practices include:

• Regular Eye Exams: Often every few months in infancy and childhood
• Imaging: Use of ultrasound, MRI to detect tumors not visible by standard examination
• Extended Screening: Lifelong monitoring is advised due to increased risk for secondary non-eye tumors

Surveillance Protocol Example

• Newborn to 3 years: Eye exam every 3–4 months
• 3–7 years: Eye exam every 6 months
• After 7 years: Annual exams or as advised by the healthcare team

Support and Resources for Families

Managing retinoblastoma involves both medical and emotional challenges. Families can draw on a range of support services:

• Genetic Counseling: Offers individualized risk assessment, education, and guidance in decision-making
• Support Groups: Local and international groups provide community, shared experiences, and hope
• Healthcare Teams: Pediatric oncologists, ophthalmologists, geneticists, and counselors coordinate comprehensive care

Organizations & Resources:

1. Retinoblastoma International: Information and advocacy
2. Childhood Eye Cancer Trust: Support and funding for research
3. Centre For Sight:  Specialized care, world-class treatment, and long-term follow-up

Why Choose Centre For Sight for Retinoblastoma Care?

Families seeking guidance for retinoblastoma eye cancer in Hyderabad, Delhi NCR, Kolkata, Punjab, Uttar Pradesh,  Mumbai or other Indian cities can consult an experienced eye specialist for an initial evaluation. If a child has been diagnosed with retinoblastoma cancer or has a family history of the condition, the doctor may recommend regular eye examinations, genetic counselling, or RB1 gene testing.

These assessments can help identify whether the eye tumour may be hereditary and whether siblings or other family members require screening. Parents can contact their nearest Centre For Sight centre to confirm the availability of the appropriate specialist and required services.